Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial

NCT07396155 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Nephropathy Type 2

Interventions

BIOLOGICAL: Umbilical Cord Mesenchymal Stem Cells

Sponsor

PT. Prodia Stem Cell Indonesia

Collaborators

[object Object]